OBX · Forms 3, 4, 5
Insider trades at Obsidian Therapeutics, Inc.
No open-market insider buys or sells at Obsidian Therapeutics, Inc. in the last 90 days; 14 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Obsidian Therapeutics, Inc. (OBX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Robert W. Ross | Director | Options or other derivatives | Form 4 | ||||
| Matthew Norkunas | Director | Options or other derivatives | Form 4 | ||||
| Madan Jagasia | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Peter Barrett | Director | Options or other derivatives | Form 4 | ||||
| Heidi Hagen | Director | Options or other derivatives | Form 4 | ||||
| Maria Fardis | Director | Options or other derivatives | Form 4 | ||||
| Peter Barrett | Director | Became an insider (Form 3) | Form 3 | ||||
| Maria Fardis | Director | Became an insider (Form 3) | Form 3 | ||||
| Julie B Feder | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Heidi Hagen | Director | Became an insider (Form 3) | Form 3 | ||||
| Madan Jagasia | Chief Executive Officer | Became an insider (Form 3) | Form 3 | ||||
| Matthew Norkunas | Director | Became an insider (Form 3) | Form 3 | ||||
| Parameswaran Hari | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Robert W. Ross | Director | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.